BLISS GVS PHARMA LTD (BLISSGVS)

NSE: ₹456.20
BSE: ₹456.85
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. June 11, 2026 has approved the allotment of 267250 equity shares of face value Re.1/- each to the eligible employees who have exercised their options under Bliss GVS Pharma Limited-Employee Stock Option Plan (Bliss GVS-ESOP 2019)

2026-06-11 17:19:46
Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Please find attached a copy of the Draft Letter of Offer (DLOF) from SBI Capital Markets Limited, the Manager to the Open Offer.

2026-06-09 19:27:05
Intimation Of WHO-GMP Compliance Of Manufacturing Facility

Please find attached an intimation of WHO-GMP compliance of manufacturing facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East).

2026-06-02 19:28:45
Detailed Public Statement In Relation To Open Offer Made To The Public Shareholders Of The Company

Please find attached a copy of newspaper publication regarding the Detailed Public Statement in connection with the Open Offer made to the public shareholders of the Company.

2026-06-01 18:54:53
Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find enclosed herewith the Annual Secretarial Compliance Report for the year ended March 31, 2026.

2026-05-28 16:31:49
Announcement under Regulation 30 (LODR)-Change in Management

Intimation of Completion of Term of Mr. Santosh Parab (DIN: 01622988) as an Independent Director of the Company.

2026-05-25 19:03:18

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 159.52 211.88 200.72 198.13 183.64 217.68 210.42 197.99 207.47 244.40 218.25 256.99
YOY Revenue Growth % -15.45% 22.88% -2.43% 7.22% 15.12% 2.74% 4.83% -0.07% 12.97% 12.27% 3.72% 29.8%
Other Income 5.11 12.60 5.42 5.60 4.12 5.04 15.27 12.07 35.45 20.18 18.46 11.16
Total Income 164.63 224.48 206.14 203.73 187.77 222.72 225.68 210.05 242.92 264.58 236.71 268.15
Total Expenses + 142.99 165.35 166.10 178.48 157.69 187.01 189.26 186.61 179.81 223.94 193.30 223.23
Cost of Materials Consumed 71.29 89.57 90.97 87.28 98.48 100.01 97.41 76.61 93.41 95.37 86.22 111.26
Employee Benefit Expense 23.52 23.26 24.29 24.51 26.54 27.51 29.76 28.24 31.00 33.35 35.94 36.14
Other Expenses 27.36 34.51 30.25 49.80 37.63 33.77 36.67 49.23 43.25 61.24 45.86 62.96
Operating Profit 16.53 46.53 34.62 19.65 25.95 30.67 21.15 11.37 27.66 20.45 24.95 33.76
OPM % 10.4% 22% 17.2% 9.9% 14.1% 14.1% 10.1% 5.7% 13.3% 8.4% 11.4% 13.1%
Profit Before Tax + 21.65 59.13 40.04 -3.95 30.07 35.71 36.42 23.44 63.11 40.63 40.90 44.95
Tax Expense 7.27 16.09 10.97 0.96 7.97 10.01 10.62 6.79 18.75 12.04 16.12 7.95
Tax % 33.6% 27.2% 27.4% - 26.5% 28% 29.1% 29% 29.7% 29.6% 39.4% 17.7%
Profit After Tax 14.37 43.04 29.07 -4.91 22.11 25.69 25.80 16.65 44.36 28.59 24.78 37.00
EPS (Basic) 1.41 4.06 2.64 -0.88 1.97 2.31 2.27 1.47 4.08 2.58 2.20 3.37

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 927.11 809.73 770.24 751.59 747.45 577.21 689.31
YOY Revenue Growth % 14.5% 5.13% 2.48% 0.55% 29.5% -16.26% -
Other Income 73.53 36.49 28.74 17.79 31.49 20.22 37.12
Total Income 1,000.64 846.22 798.98 769.37 778.95 597.43 726.43
Total Expenses + 808.57 720.58 652.91 663.30 651.19 493.30 382.73
Cost of Materials Consumed 386.26 372.51 339.12 330.04 385.27 259.81 256.62
Employee Benefit Expense 136.43 112.05 95.58 86.17 76.15 68.09 53.69
Other Expenses 201.58 157.30 141.92 146.77 161.98 73.56 72.42
Operating Profit 118.55 89.15 117.33 88.29 96.27 83.90 306.58
OPM % 12.8% 11% 15.2% 11.7% 12.9% 14.5% 44.5%
Profit Before Exceptional 192.08 125.64 146.07 106.07 127.76 104.13 142.35
Exceptional Items -2.49 0.00 -29.20 0.00 -73.59 0.00 -13.38
Profit Before Tax + 189.59 125.64 116.87 106.07 54.17 104.13 128.97
Tax Expense 54.86 35.38 35.29 29.34 31.04 30.16 33.71
Tax % 28.9% 28.2% 30.2% 27.7% 57.3% 29% 26.1%
Profit After Tax 134.73 90.26 81.58 76.73 23.13 73.97 95.25
EPS (Basic) 12.23 8.02 7.23 6.83 1.46 6.64 9.43

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 546.08 474.33 402.25 459.49 332.71 311.59 0.00
Property, Plant & Equipment 450.68 397.01 361.55 370.11 272.67 225.43 0.00
Capital Work in Progress 6.05 20.71 7.83 2.80 22.15 2.39 0.00
Non-Current Investments 3.52 4.38 3.61 2.84 2.39 0.01 0.00
Goodwill 7.71 7.71 7.71 7.71 7.71 7.71 0.00
Other Intangible Assets 0.21 0.23 0.11 0.23 0.38 0.58 0.00
Current Assets + 946.34 819.33 811.62 697.37 776.03 765.20 0.00
Inventories 150.73 125.73 118.45 103.06 123.94 98.93 0.00
Trade Receivables 517.19 438.36 404.35 385.17 392.75 463.82 0.00
Cash and Cash Equivalents 35.14 23.79 23.14 24.96 21.92 12.63 0.00
Current Investments 1.45 0.00 0.56 4.96 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 1,231.76 1,091.85 1,002.98 917.42 846.46 827.91 0.00
Equity Share Capital 10.58 10.54 10.47 10.42 10.37 10.31 0.00
Other Equity 1,182.32 1,039.84 956.72 873.48 808.33 797.94 0.00
Non-Current Liabilities 25.11 37.28 51.06 46.17 29.20 45.24 0.00
Current Liabilities 235.54 171.72 159.82 193.26 233.09 203.64 0.00
Total Liabilities 260.65 208.99 210.89 239.43 262.28 248.88 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 138.72 105.91 152.45 34.31 135.48 63.97 0.00
Cash from Investing Activities -38.28 -75.44 -132.82 -7.75 -92.98 -46.99 0.00
Cash from Financing Activities -89.21 -30.34 -20.89 -24.94 -23.73 -20.80 0.00
Net Increase/Decrease in Cash 11.32 0.23 -1.42 3.02 18.78 -2.21 0.00